ConductScience.org, home

Paper604194

Bile acid studies in uncomplicated Crohn's disease.

Vantrappen G and 3 others. Gut, 1977. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Bile acid studies in uncomplicated Crohn's disease. Papers, record 604194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/604194

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bile acid studies in uncomplicated Crohn's disease.
PubMed
Journal
Gut
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
1.49
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vantrappen GG
2Ghoos YY
3Rutgeerts PP
4Janssens JJ

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bile Acids and SaltsMajor topic
Crohn DiseaseMajor topic
Adolescent
Adult
Colitis, Ulcerative
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16021786Importance of bile acids and of an intact distal small intestine for fat absorption.Gastroenterology1967https://conductscience.org/library/papers/6021786PubMed
212066774Bile salt malabsorption in regional ileitis, ileal resection and mannitol-induced diarrhea.J Clin Invest1968https://conductscience.org/library/papers/12066774PubMed
311344576Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.J Clin Invest1974https://conductscience.org/library/papers/11344576PubMed
44983661Effects of controlled interruption of the enterohepatic circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis, and pool size in the rhesus monkey.J Clin Invest1970https://conductscience.org/library/papers/4983661PubMed
54917494The pathophysiological role of small intestinal bacterial flora.Scand J Gastroenterol Suppl1970https://conductscience.org/library/papers/4917494PubMed
64186005Increased ratio of glycine- to taurine-conjugated bile salts in patients with ileal disorders.Gastroenterology1969https://conductscience.org/library/papers/4186005PubMed
755588Abnormalities in the apparently normal bowel mucosa in Crohn's disease.Lancet1976https://conductscience.org/library/papers/55588PubMed
855808Letter: Bowel mucosa in Crohn's disease.Lancet1976https://conductscience.org/library/papers/55808PubMed
94595082Bile acid metabolism in infants and children.Gut1974https://conductscience.org/library/papers/4595082PubMed
104434644Measurement and validation of human bile salt pool size and synthesis.Clin Chim Acta1974https://conductscience.org/library/papers/4434644PubMed
114683854Patterns of bile acids and microflora in the human small intestine. I. Bile acids.Gastroenterology1973https://conductscience.org/library/papers/4683854PubMed
125059435Relationship of bile acid pool size to the formation of lithogenic bile in female Indians of the southwest.Gastroenterology1972https://conductscience.org/library/papers/5059435PubMed
135029077
Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.
Gastroenterology1972https://conductscience.org/library/papers/5029077PubMed
145040830Lithogenic bile in patients with ileal dysfunction.Gut1972https://conductscience.org/library/papers/5040830PubMed
155337211The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy.Gastroenterology1967https://conductscience.org/library/papers/5337211PubMed
161092784Determination of bile acid pool size in man: a simplified method with advantages of increases precision, shortened analysis time, and decreased isotope exposure.J Lipid Res1975https://conductscience.org/library/papers/1092784PubMed
17954753Sulfate bile acids in germ-free and conventional mice.Eur J Biochem1976https://conductscience.org/library/papers/954753PubMed
181265436Bile acids in bile during long-term chenodeoxycholic acid treatment.Scand J Gastroenterol1976https://conductscience.org/library/papers/1265436PubMed
19935802The disease activity of ulcerative colitis and Crohn's disease.Scand J Gastroenterol1976https://conductscience.org/library/papers/935802PubMed
201238741[Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid].Nihon Shokakibyo Gakkai Zasshi1975https://conductscience.org/library/papers/1238741PubMed

See all 28 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
41882686Matrine improves bile acid metabolism and reduces inflammatory and oxidative stress in colitis via the JAK2 pathway.Chin Med2026https://conductscience.org/library/papers/41882686PubMed
40873453An overview of basic pathophysiological interactions between gut bacteria and their host.Front Nutr2025https://conductscience.org/library/papers/40873453PubMed
40692955Bile acids affect intestinal barrier function through FXR and TGR5.Front Med (Lausanne)2025https://conductscience.org/library/papers/40692955PubMed
39188957The involvement of oral bacteria in inflammatory bowel disease.Gastroenterol Rep (Oxf)2024https://conductscience.org/library/papers/39188957PubMed
39179591Hepatic Gα13 ablation shifts region-specific colonic inflammatory status by modulating the bile acid synthetic pathway in mice.Sci Rep2024https://conductscience.org/library/papers/39179591PubMed
37515676The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease.Intern Emerg Med2023https://conductscience.org/library/papers/37515676PubMed
37508557Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases.Cells2023https://conductscience.org/library/papers/37508557PubMed
37256134Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity.Front Immunol2023https://conductscience.org/library/papers/37256134PubMed
36740850Bile acids as modulators of gut microbiota composition and function.Gut Microbes2023https://conductscience.org/library/papers/36740850PubMed
36569849Bile acids as inflammatory mediators and modulators of intestinal permeability.Front Immunol2022https://conductscience.org/library/papers/36569849PubMed
36211363Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.Front Immunol2022https://conductscience.org/library/papers/36211363PubMed
35955491Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches.Int J Mol Sci2022https://conductscience.org/library/papers/35955491PubMed
35807844Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis.Nutrients2022https://conductscience.org/library/papers/35807844PubMed
35269523Bile Acids: Key Players in Inflammatory Bowel Diseases?Cells2022https://conductscience.org/library/papers/35269523PubMed
34830388Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.Int J Mol Sci2021https://conductscience.org/library/papers/34830388PubMed
34746509Ursodeoxycholic Acid Triggers Primary Enterolith Growth in a Crohn's Disease Patient with Jejunal Stenosis.J Anus Rectum Colon2021https://conductscience.org/library/papers/34746509PubMed
34445800Bile Acid Signaling in Inflammatory Bowel Disease.Int J Mol Sci2021https://conductscience.org/library/papers/34445800PubMed
34064187Bile Acids Activated Receptors in Inflammatory Bowel Disease.Cells2021https://conductscience.org/library/papers/34064187PubMed
34063522Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products.Biomolecules2021https://conductscience.org/library/papers/34063522PubMed
33289902Bile Acid Signaling in Inflammatory Bowel Diseases.Dig Dis Sci2021https://conductscience.org/library/papers/33289902PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/604194

GET https://conductscience.org/api/papers/v1/604194/references?page=2